Research output per year
Research output per year
Personal profile
Curriculum
Education
2001: M.D, University of Southern Denmark, Denmark
Academic Degrees and Appointments
2008: Ph.D, University of Southern Denmark, Denmark. ”The JAK2 V617F mutation in Philadelphia chromosome negative chronic myeloproliferative disorders – Impact on clinical phenotype”.
2004-2007: Research Fellow at University of Southern Denmark, Denmark
Clinical Appointments
2001-2003 Resident. Sygehus Fyn Svendborg-Faaborg, Denmark
2003-2004 House Officer. Dept. of Hematology,Odense University Hospital, Denmark.
2008: Senior House Officer. Dept. of Hematology, Odense University Hospital, Denmark.
2008- 2010: Senior House Officer. Dept. of Internal medicine, Vejle Hospital, Denmark
2010 - 2013: Senior House Officer. Dept. of Hematology, Odense University Hospital, Denmark
2013 - Consultant. Dept. of Haematology, Odense University Hospital, Denmark
Academic Appointments
2013 – Associate Professor of Haematology, Faculty of Medical Sciences, University of Southern Denmark
Relevant positions
Member of the Danish Society of Hematology
Member of board, Danish Studygroup on Chronic Myeloid Disease (DSKMS)
Member of the Nordic MPD Study Group.
Member of European Cooperation in Science and Technology (COST) Biomedicin and
Molecular Biosciences (BMBS) action BM0902 on MPD.
Member of Recommendation board on stem cell transplantation, Danish Society of Hematology.
Head of Board, Danish committee on autologous stem cell transplantation and high dose therapy, Danish Society of Hematology
Member of AgeCare (Academy of Geriatric Cancer Research). An Elite Research
Center at Odense University Hospital
Fingerprint
Fingerprints are formed from scientific publications and create an index of weighted keyword concepts for each individual researcher.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Work Disability and Return to Work After Lymphoma: A Danish Nationwide Cohort Study
Maksten, E. F., Jakobsen, L. H., Kragholm, K. H., Baech, J., Andersen, M. P., Madsen, J., Jørgensen, J. M., Clausen, M. R., Pedersen, R. S., Dessau-Arp, A., Larsen, T. S., Poulsen, C. B., Gang, A. O., Brown, P., Fonager, K., El-Galaly, T. C. & Severinsen, M. T., 14. Mar 2023, In: Clinical Epidemiology. 15, p. 337-348Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile1 Downloads (Pure) -
A walk-in clinic as an alternative approach to reaching non-attenders of the cervical cancer screening program in the North Denmark region: a pilot study
Bonefeld, R. E., Poulsgaard Frandsen, A., Christensen, J., Larsen, T. & Kahr, H. S., Jun 2022, In: Acta Obstetricia et Gynecologica Scandinavica. 101, 6, p. 693-698Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile17 Downloads (Pure) -
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine
Gigoux, M., Holmström, M. O., Zappasodi, R., Park, J. J., Pourpe, S., Bozkus, C. C., Mangarin, L. M. B., Redmond, D., Verma, S., Schad, S., George, M. M., Venkatesh, D., Ghosh, A., Hoyos, D., Molvi, Z., Kamaz, B., Marneth, A. E., Duke, W., Leventhal, M. J., Jan, M., & 23 others, 15. Jun 2022, In: Science Translational Medicine. 14, 649, eaba4380.Research output: Contribution to journal › Journal article › Research › peer-review
-
Cardiovascular diseases in elderly survivors of diffuse large B-cell lymphoma: a Danish population-based cohort study
Juul, M. B., Jelicic, J., Anru, P. L., Engberg, H., Hammershøj Jensen, P., Kristensen, H. B., Baech, J., Clausen, M. R., Gang, A. O., Munksgaard, L., El-Galaly, T. C., Frederiksen, H. & Stauffer Larsen, T., Sept 2022, In: Leukemia and Lymphoma. 63, 9, p. 2074-2083Research output: Contribution to journal › Journal article › Research › peer-review
-
Clinical Characteristics and Management of Patients With Concomitant Liver Cirrhosis and Lymphoma: A Systematic Review
Jelicic, J., Larsen, T. S., Fialla, A. D., Bukumiric, Z. & Andjelic, B., Nov 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, 11, p. e981-e991Research output: Contribution to journal › Journal article › Research › peer-review
Activities
-
Reproduktiv Patterns Among Non-Hodgkin Lymphoma Survivors By Subtype in Sweden, Denmark and Norway
Joshua P.P. Entrop (Guest lecturer), Caroline E Weibull (Guest lecturer), Karin E Smedby (Guest lecturer), Lasse Hjort Jakobsen (Guest lecturer), Andreas K Øvlisen (Guest lecturer), Ingrid Glimelius (Guest lecturer), Anna Marklund (Guest lecturer), Thomas Stauffer Larsen (Guest lecturer), Harald Holte (Guest lecturer), Alexander Fossa (Guest lecturer), Knut B. Smeland (Guest lecturer), Tarec Christoffer El-Galaly (Guest lecturer) & Sandra Eloranta (Guest lecturer)
Dec 2022Activity: Talks and presentations › Conference presentations
-
The Impact of Trial Eligibility Criteria on Outcomes in a Nationwide Cohort of Newly Diagnosed DLBCL Patients Treated with R-CHOP
Freja Tang Severinsen (Speaker), Laura Mors Haunstrup, (Co-author), Rasmus Kuhr Jensen (Co-author), Matthew J Maurer (Co-author), Arushi Khurana (Co-author), Paw Jensen (Co-author), Judith M. Jørgensen (Co-author), Thomas Stauffer Larsen (Guest lecturer), Michael Roost Clausen (Co-author), Christian Bjørn Poulsen (Co-author), Peter de Nully Brown (Guest lecturer), Tarec Christoffer El-Galaly (Co-author) & Lasse Hjort Jakobsen (Co-author)
5. Nov 2021Activity: Talks and presentations › Conference presentations
-
Glofitamab (Glofit) in Combination with Polatuzumab Vedotin (Pola): Phase Ib/II Preliminary Data Support Manageable Safety and Encouraging Efficacy in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
Martin Hutchings (Speaker), Anna Sureda Balari (Co-author), Maria Jose Terol (Co-author), Francesc Bosch Albareda (Co-author), Paolo Corradini (Co-author), Thomas Stauffer Larsen (Co-author), Antonio Rueda Dominguez (Co-author), Anesh Panchal (Co-author), Alessia Bottos (Co-author), David Carlile (Co-author), Yanjie Wang (Co-author), Audrey Filézac De L'Étang (Co-author), Maneesh Tandon (Co-author), Gila Sellam (Co-author) & Giuseppe Gritti (Co-author)
Nov 2021Activity: Talks and presentations › Conference presentations
-
CAR-T - placering af en ny terapiform i fremtidens behandling af hæmatologisk kræft. Hvad er CAR-T? - perspektiver og udfordringer
Thomas Stauffer Larsen (Guest lecturer)
29. Jun 2021Activity: Talks and presentations › Talks and presentations in private or public companies
-
BIOMARKER‐DRIVEN TREATMENT STRATEGY IN HIGH RISK DIFFUSE LARGE B‐CELL LYMPHOMA: RESULTS OF A NORDIC PHASE 2 STUDY
S Leppa (Author), J Jørgensen (Co-author), ML Karjalainen-Lindsberg (Co-author), Beiske K. (Co-author), P. Nørgaard (Co-author), K. Drott (Co-author), Pasanen A (Co-author), Karihtala K (Co-author), Mannisto S. (Co-author), Wold B (Co-author), Brodtkorb M. (Co-author), M Fagerli (Co-author), Thomas Stauffer Larsen (Co-author), Lars Munksgaard (Co-author), Ø Fluge (Co-author), S Jyrkkiö (Co-author), Peter de Nully Brown (Co-author) & H. Holte (Co-author)
17. Jun 2021Activity: Talks and presentations › Conference presentations
Press/Media
-
Kongres for specialister i blodsygdomme kastede store og potentielt praksisændrende resultater af sig
03/01/2023
1 Media contribution
Press/Media: Press / Media
-
ASH 2022 kastede flere store og potentielt praksisændrende resultater af sig
22/12/2022
1 Media contribution
Press/Media: Press / Media
-
Største studie i primær CNS-lymfom til dato konfirmerer nuværende standard-konsolidering
13/12/2022
1 Media contribution
Press/Media: Press / Media
-
CAR-T har potentiale mod solide tumorer, men implementeringen står i stampe i Danmark
27/04/2022
1 Media contribution
Press/Media: Press / Media
-
Kræftlæge: Ny behandlingsform står i stampe i Danmark
27/04/2022
1 Media contribution
Press/Media: Press / Media